15th International Myeloma Foundation gala raises over $675K Myeloma Research News - 30 Apr 2024 15th International Myeloma Foundation gala raises over $675K ... More
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma OncLive - 29 Apr 2024 Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ... More
Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma www.oncnursingnews.com/ - 27 Apr 2024 Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma ... More
Daratumumab Plus Standard Therapy for Multiple Myeloma National Cancer Institute (.gov) - 19 Jan 2024 Daratumumab Plus Standard Therapy for Multiple Myeloma ... More
What Is a FISH Test in Multiple Myeloma? - HealthTree For AML Acute Myeloid Leukemia - 22 Apr 2024 What Is a FISH Test in Multiple Myeloma? ... More
Mayo Clinic Minute: Advances in multiple myeloma treatment Mayo Clinic - 12 Mar 2024 Mayo Clinic Minute: Advances in multiple myeloma treatment ... More
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease Nature.com - 19 Mar 2024 The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease ... More
RESEARCH ALERT: Stopping Multiple Myeloma Cedars-Sinai - 07 Feb 2024 RESEARCH ALERT: Stopping Multiple Myeloma ... More
New study points to racial and social barriers that block treatment for multiple myeloma UC Davis Health - 23 Apr 2024 New study points to racial and social barriers that block treatment for multiple myeloma ... More
Discussing Myeloma Research With Dr. Adeel Khan - HealthTree For AML Acute Myeloid Leukemia - 25 Apr 2024 Discussing Myeloma Research With Dr. Adeel Khan ... More
Rheological properties of blood in multiple myeloma patients | Scientific Reports Nature.com - 21 Feb 2024 Rheological properties of blood in multiple myeloma patients | Scientific Reports ... More
ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy OncLive - 25 Apr 2024 ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy ... More
The enduring neutrophil–stroma dance of multiple myeloma Nature.com - 10 Apr 2024 The enduring neutrophil–stroma dance of multiple myeloma ... More
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy OncLive - 22 Apr 2024 European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ... More
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT ... Nature.com - 21 Feb 2024 Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT ... ... More
Mode of progression in smoldering multiple myeloma: a study of 406 patients | Blood Cancer Journal Nature.com - 17 Jan 2024 Mode of progression in smoldering multiple myeloma: a study of 406 patients | Blood Cancer Journal ... More
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal Nature.com - 05 Mar 2024 Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal ... More
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal Nature.com - 25 Jan 2024 Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal ... More